Report on HIV/AIDS from IDSA: news from the mile high city.
Bartlett
J G
JG
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines; D003120:Colorado; D003521:Cyclopropanes; D015224:Dideoxynucleosides / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D010078:Oxazines / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control; D010818:Practice Patterns, Physicians'; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D014376:Tuberculosis / Q000517:prevention & control; D014481:United States; D000099227:Abacavir
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D007376:Interleukin-2; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir; C098320:efavirenz